Invesco falls 6.2% as fresh Wall Street cuts and market-sensitive flow worries weigh on asset managers

Invesco Ltd. (IVZ) is down 6.2% today. Here is some analysis on what might have caused this price movement.

Analysis: The drop appears tied to a recent wave of more cautious analyst outlooks that lowered expectations for 2025–2026 results as market levels and investor risk appetite softened, which can pressure both assets under management and fee revenue. With IVZ viewed as highly sensitive to equity and ETF flows, the shares may be reacting to concerns that weaker markets translate quickly into lower AUM and earnings power.

Details:

A major bank recently lowered its price target on IVZ while maintaining a neutral-style rating, citing slower growth and uncertainty as headwinds for flows and earnings estimates.

Invesco disclosed preliminary month-end AUM for February 2026 of about $2.26 trillion, showing how monthly AUM can swing with a mix of client flows and market performance.

The company is approaching its next earnings report date later this month, which can amplify sensitivity to estimate revisions and positioning in the days beforehand.

This could also reflect broader, same-day pressure on asset managers when equity and bond markets fall, since management fees are typically linked to average AUM.

Sources:

StreetInsider, Stock Titan (SEC filing/8-K), Benzinga

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$IVZ Insider Trading Activity

$IVZ insiders have traded $IVZ stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $IVZ stock by insiders over the last 6 months:

DOUGLAS J SHARP (Senior Managing Director) sold 160,000 shares for an estimated $3,768,832

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$IVZ Hedge Fund Activity

We have seen 333 institutional investors add shares of $IVZ stock to their portfolio, and 223 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

TRIAN FUND MANAGEMENT, L.P. removed 11,657,511 shares (-79.7%) from their portfolio in Q4 2025, for an estimated $306,242,813
INVESCO LTD. added 8,770,121 shares (+inf%) to their portfolio in Q4 2025, for an estimated $230,391,078
PRICE T ROWE ASSOCIATES INC /MD/ added 5,292,867 shares (+368.4%) to their portfolio in Q4 2025, for an estimated $139,043,616
CITADEL ADVISORS LLC removed 4,119,003 shares (-82.7%) from their portfolio in Q4 2025, for an estimated $108,206,208
BALYASNY ASSET MANAGEMENT L.P. removed 3,300,789 shares (-99.2%) from their portfolio in Q4 2025, for an estimated $86,711,727
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 2,970,710 shares (-75.8%) from their portfolio in Q4 2025, for an estimated $78,040,551
SAMLYN CAPITAL, LLC added 2,268,260 shares (+116.8%) to their portfolio in Q4 2025, for an estimated $59,587,190

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$IVZ Congressional Stock Trading

Members of Congress have traded $IVZ stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $IVZ stock by members of Congress over the last 6 months:

REPRESENTATIVE KEVIN HERN sold up to $50,000 on 03/17.
REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 01/09 and 1 sale worth up to $15,000 on 02/10.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$IVZ Analyst Ratings

Wall Street analysts have issued reports on $IVZ in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

RBC Capital issued a "Outperform" rating on 01/21/2026
Deutsche Bank issued a "Buy" rating on 12/17/2025

To track analyst ratings and price targets for $IVZ, check out Quiver Quantitative's $IVZ forecast page.

$IVZ Price Targets

Multiple analysts have issued price targets for $IVZ recently. We have seen 10 analysts offer price targets for $IVZ in the last 6 months, with a median target of $30.0.

Here are some recent targets:

Michael Cyprys from Morgan Stanley set a target price of $26.0 on 04/01/2026
Alexander Blostein from Goldman Sachs set a target price of $30.0 on 02/12/2026
Kenneth S. Lee from RBC Capital set a target price of $33.0 on 01/28/2026
Stephen Biggar from Argus Research set a target price of $31.0 on 01/28/2026
Benjamin Budish from Barclays set a target price of $29.0 on 01/28/2026
Kenneth Worthington from JP Morgan set a target price of $30.0 on 01/20/2026
Brian Bedell from Deutsche Bank set a target price of $31.0 on 12/17/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.